588 related articles for article (PubMed ID: 27651011)
1. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
Desmidt T; Hommet C; Camus V
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of behavioral symptoms in dementia patients].
Gabryelewicz T
Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
5. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
Hommet C; Novella JL; Auriacombe S; Vercelletto M; Berrut G; Belliard S; Desmidt T; Ceccaldi M
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):274-86. PubMed ID: 27651009
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological treatment in severe dementia].
Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
[TBL] [Abstract][Full Text] [Related]
8. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
[TBL] [Abstract][Full Text] [Related]
9. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
[TBL] [Abstract][Full Text] [Related]
10. Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Koike M; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
J Alzheimers Dis; 2015; 47(2):487-93. PubMed ID: 26401570
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
14. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
[TBL] [Abstract][Full Text] [Related]
15. [The Adaptation of Anti-dementia Drugs for BPSD].
Hashimoto M
Seishin Shinkeigaku Zasshi; 2016; 118(6):436-442. PubMed ID: 30620504
[TBL] [Abstract][Full Text] [Related]
16. [Antidementia drugs].
Müller-Spahn F; Sollberger D; Wollmer MA
Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
[TBL] [Abstract][Full Text] [Related]
17. Memantine for treatment of moderate to severe Alzheimer's disease.
Perras C
Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
Pinto T; Lanctôt KL; Herrmann N
Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
[TBL] [Abstract][Full Text] [Related]
19. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Alzheimer disease.
Winslow BT; Onysko MK; Stob CM; Hazlewood KA
Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
